Oon C J, Chen W N
Department of Clinical Research, Ministry of Health, Singapore General Hospital, Republic of Singapore.
J Viral Hepat. 1998 Nov;5 Suppl 2:17-23. doi: 10.1046/j.1365-2893.1998.0050s2017.x.
Mutations occurring on the major antigenic 'a' determinant of hepatitis B surface antigen (HBsAg) have been detected in immunized Singapore children, despite immunoprophylaxis with hepatitis B immune globulin and HBV vaccine. These vaccine-escape HBsAg mutants display a predominance of the Gly145-to-Arg145 mutation in the antigenic 'a' determinant. Our latest follow-up studies indicate the stability of this as well as other vaccine-escape HBsAg mutants over time. We have also identified HBsAg mutants in immunized children with amino acid substitutions outside the 'a' determinant. Transmission of various vaccine-escape HBsAg mutants have been shown in our epidemiological studies. Detection of HBsAg mutants, carrying amino acid changes at various position of the 'a' determinant in random population, points to their emergence in Singapore before the implementation of the vaccination programme. Of significant interest is the recent identification of vaccine-escape HBsAg mutants in hepatocellular carcinoma.
尽管对新加坡儿童进行了乙肝免疫球蛋白和乙肝疫苗的免疫预防,但在这些儿童中仍检测到乙肝表面抗原(HBsAg)主要抗原性“a”决定簇发生的突变。这些疫苗逃逸型HBsAg突变体在抗原性“a”决定簇中以Gly145突变为Arg145为主。我们最新的随访研究表明,这种以及其他疫苗逃逸型HBsAg突变体随时间推移具有稳定性。我们还在接受免疫的儿童中鉴定出了“a”决定簇以外发生氨基酸替代的HBsAg突变体。我们的流行病学研究显示了各种疫苗逃逸型HBsAg突变体的传播情况。在随机人群中检测到“a”决定簇不同位置发生氨基酸变化的HBsAg突变体,表明它们在新加坡疫苗接种计划实施之前就已出现。最近在肝细胞癌中鉴定出疫苗逃逸型HBsAg突变体,这一点非常值得关注。